Home/Publication/Northern Light et al to Treat Parkinson’s with Cell Therapy
Northern Light et al to Treat Parkinson’s with Cell Therapy 

05 Sep 2025

US$ 20.00

Northern Light Venture Capital and GSR United Capital were party to the series B+ funding round of iRegene Therapeutics...

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 5 September 2025...

Listen to Australia/New Zealand Investments (Subscribers' Weekly 05 Sep 2025)...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.